Loading [Contrib]/a11y/accessibility-menu.js

Challenges for Accessibility of Blood Derivatives products in Egypt

Research Article | DOI: https://doi.org/10.31579/2640-1053/153

Challenges for Accessibility of Blood Derivatives products in Egypt

  • Lizaveta I. Bon 1*
  • Fliuryk S 2
  • Dremza I 2
  • Bon E 2
  • Maksimovich N 2
  • Prykhodzka A 2
  • Kendysh U 2
  • Pauliuchenkava D 2
  • Misyuk V.A. 2
  • Voronchikhin G.U. 2

1WHO Project Manger 

2GLSBOR Elected President

*Corresponding Author: Abdalla Abotaleb, WHO Project Manger GLSBOR Elected President.

Citation: Abdalla Abotaleb (2023), Challenges for Accessibility of Blood Derivatives products in Egypt, J Cancer Research and Cellular Therapeutics, 7(3); DOI:10.31579/2640-1053/153

Copyright: © 2023, Lizaveta I. Bon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 26 June 2023 | Accepted: 07 July 2023 | Published: 18 July 2023

Keywords: blood derivatives accepility; Egypt; abdalla abotaleb

Abstract

Background

Haigh population with low middle income for a country like Egypt might Create a challenge on Health care system resources and affect on Priorization of health system needs. With critical products like blood derivatives several elements might affect accessibility for these products.

The objective for this research is analyzing   from policy perspective these elements in order to enhance Accepility for the patients which will lead to System Enhancement 

Methods     

Integration between survey Analysis for 125 of Health care professionals in Egypt Including (Physicians, Pharmacists, Supply chain Managers and payers) plus stock and sales analysis for previous 5 years. One way sensitivity analysis was conducted for robustness of data guaranteeing     

Results 

The following Results were fended. 

Introduction

Localization of Blood Derivatives manufacturing Process might enhance Accepility through Controlling of Prices plus availability enhancement which will lead to Resources utilization 

Background

Haigh population with low middle income for a country like Egypt might Create a challenge on Health care system resources and affect on 

Priorization of health system needs. With critical products like blood derivatives several elements might affect accessibility for these products.

The objective for this research is analyzing   from policy prospective these elements in order to enhance Accepility for the patients which will lead to System Enhancement 

Figure 1: Regional distribution of population and blood donations by WHO region and World Bank income group, 2013

Figure 2: Jean Sterne, a French physician (1909-1997)

Figure 3: Middle East and Africa Artificial Blood Substitutes Market is Expected

Figure 4: Number of Blood Centers in the country

Figure 5: Number of whole blood donations collected

Figure 6: Proportions of voluntary non-remunerated whole blood donations by WHO region and World Bank income group, 2013

Figure 7: The World-Wide Plasma Products Market - 2020 By Region

Methods

Integration between survey Analysis for 125 of Health care professionals in Egypt Including (Physicians, Pharmacists, Supply chain Managers and payers) plus stock and sales analysis for previous 5 years. One way sensitivity analysis was conducted for robustness of data guaranteeing   

Results

 The following Results were fended

Figure 8: Albumine Case

Figure 9: IVIG Case

Conclusion

Localization of Blood Derivatives manufacturing Process might enhance Accepility through Controlling of Prices plus availability enhancement which will lead to Resources utilization 

References

a